Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enanta Pharmaceutica (ENTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,292,937
  • Shares Outstanding, K 19,270
  • Annual Sales, $ 102,810 K
  • Annual Income, $ 17,710 K
  • 36-Month Beta 1.07
  • Price/Sales 22.41
  • Price/Cash Flow 107.19
  • Price/Book 6.63

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.30 +25.50%
on 05/29/18
122.43 -2.31%
on 06/11/18
+19.08 (+18.98%)
since 05/22/18
3-Month
75.92 +57.53%
on 03/28/18
122.43 -2.31%
on 06/11/18
+36.46 (+43.85%)
since 03/22/18
52-Week
33.15 +260.78%
on 07/10/17
122.43 -2.31%
on 06/11/18
+82.49 (+222.29%)
since 06/22/17

Most Recent Stories

More News
Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy

Smaller drugmakers are having a relatively better year than their larger counterparts. Here are seven stocks to buy.

RDHL : 7.90 (+0.77%)
ACER : 20.68 (+7.43%)
JAZZ : 178.50 (-0.90%)
COOL : 38.73 (-0.62%)
ACRX : 4.00 (-1.23%)
ENTA : 119.60 (+0.51%)
TARO : 117.50 (-1.14%)
Enanta Pharmaceuticals Recognizes the 1st International NASH Day

Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases,...

ENTA : 119.60 (+0.51%)
Play the Best Sector of Summer With These ETFs & Stocks

Health care is apparently one of the best-performing sectors of summer. So, track these ETFs and stocks.

XLV : 84.93 (+0.45%)
SSKN : 2.17 (+0.93%)
ENTA : 119.60 (+0.51%)
PJP : 68.17 (-0.26%)
IHE : 154.70 (+0.26%)
ODT : 24.98 (+0.64%)
Play the Best Sector of Summer With These ETFs & Stocks

Health care is apparently one of the best-performing sectors of summer. So, track these ETFs and stocks.

XLV : 84.93 (+0.45%)
SSKN : 2.17 (+0.93%)
ENTA : 119.60 (+0.51%)
PJP : 68.17 (-0.26%)
IHE : 154.70 (+0.26%)
ODT : 24.98 (+0.64%)
Today's Research Reports on Stocks to Watch: Enanta Pharmaceuticals and Vascular Biogenics

NEW YORK, NY / ACCESSWIRE / June 7, 2018 / Enanta Pharmaceuticals as well as Vascular Biogenics were two stocks in the biotech arena making big moves in Wednesday's trading session. Enanta climbed higher...

ENTA : 119.60 (+0.51%)
VBLT : 2.50 (-5.66%)
Shares of Cytomx Therapeut Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (CTMX , ENTA , RARE , INSY , AKBA )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CTMX : 24.58 (-1.09%)
RARE : 84.26 (+2.32%)
ENTA : 119.60 (+0.51%)
Why Enanta Pharmaceuticals (ENTA) Could Shock the Market Soon

Although overlooked by the investors, Enanta Pharmaceuticals (ENTA) looks well-positioned for a solid gain, supported by a favorable Zacks rank and positive estimate revisions.

ENTA : 119.60 (+0.51%)
Enanta Pharmaceuticals to Present at the NASDAQ 38th Investor Conference Presentation to be Webcast on June 12 at 9:30 A.M. GMT

Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases,...

ENTA : 119.60 (+0.51%)
Bayer's Generic Competition, Pipeline Setback Issues Remain

Generic threats/competition for many of its products remain a concern for Bayer (BAYRY).

BAYRY : 29.0200 (+1.47%)
LGND : 198.40 (-0.63%)
ILMN : 282.65 (-1.19%)
ENTA : 119.60 (+0.51%)
Is Guggenheim S&P SmallCap 600 Pure Growth ETF (RZG) a Hot ETF Right Now?

Smart Beta ETF report for RZG

QLYS : 88.80 (-6.33%)
IWO : 210.14 (-0.77%)
ENTA : 119.60 (+0.51%)
BEAT : 46.05 (-0.54%)
RZG : 129.24 (-0.62%)
VBK : 179.58 (-0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade ENTA with:

Business Summary

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown,...

See More

Key Turning Points

2nd Resistance Point 123.46
1st Resistance Point 121.53
Last Price 119.60
1st Support Level 117.91
2nd Support Level 116.22

See More

52-Week High 122.43
Last Price 119.60
Fibonacci 61.8% 88.33
Fibonacci 50% 77.79
Fibonacci 38.2% 67.25
52-Week Low 33.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar